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he article by Halabchi et al. provides a 
comprehensive, thoughtful and balanced analysis 
of the literature on sudden cardiac death (SCD) in 
young athletes 
[1]. The article is unique in providing a 
special perspective for Asia as contrasted with those in 
Europe and the United States. This aspect is extremely 
important to recognize for the management of young 
athletes in different parts of the world.  
     In  the  United  States, the history and physical 
examination (H&P) has been the standard of 
cardiovascular screening for competitive athletes, 
although several studies have questioned the efficacy of 
the screening H&P alone in identifying athletes at risk 
for cardiovascular adverse events 
[2-6]. The H&P has 
come under scrutiny for having low sensitivity for 
identifying athletes with cardiovascular risk factors. 
Several studies have reported data substantiating the 
higher efficacy of electrocardiogram (ECG) in 
identifying athletes with hypertrophic cardiomyopathy 
(HCM), channelopathies, and other clinically silent 
cardiovascular diseases that increase the risk for SCD in 
young athletes 
[2,6-12].
  
     The  Italian  experience  using  the  ECG  as  part  of 
screening athletes is cited most frequently as the basis 
for including ECG as a screening tool 
[4]. One argument 
against that study is that it is an observational study and 
not a prospective study with a control population 
[3]. At 
present there is no worldwide consensus on the added 
value of including ECG as a screening tool for all 
young athletes. In the United States the American Heart 
Association report provides the general framework for 
cardiovascular screening 
[3,5].
 
Large prospective studies 
are needed to evaluate the value of screening ECGs in 
the US population.  
     2-D echocardiogram (ECHO) is most useful for the 
diagnosis of structural heart disease 
[13].
 
Adding an 
ECHO to a cardiovascular screening program increases 
the likelihood of identifying structural abnormalities of 
the heart. The added cost of screening and the scarcity 
of resources, equipment, and personnel are significant 
barriers to recommend routine use of ECHO for 
screening. An ECHO can be considered a good 
confirmatory test after abnormal findings on H&P or 
ECG.  
     There  have  been  significant advances in the 
identification of genetic causes for cardiovascular 
diseases,
 
leading to the question of present or future 
methods involving identification of genetic risk factors 
for cardiovascular disease using genetic testing as a 
screening tool 
[14,15].  Exercise stress testing is of limited 
value as a screening tool but has a role in risk strat-
ification
[13]. Exercise stress testing has been 
recommended in athletes older than 35. This is also part 
of the extended Italian recommendation for athletes 
older than 35
[4,5].
 
Maximal exercise testing is an integral 
component to unmask arrhythmia in arrythmogenic 
ventricular cardiomyopathy (ARVC), familial catecho-
laminergic polymorphic ventricular tachycardia, and 
long QT syndrome. Frequent ventricular extrasystoles 
during exercise indicate underlying cardiac disease 
[13]. 
Several other tests are available for identification of 
certain specific conditions 
[13,15].
 
These include Holter 
T  
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monitoring (quantification of extrasystoles and 
identification of tachy-and bradyarrythmias), cardiac 
magnetic resonance imaging (MRI) scan (ARVC, 
HCM, and myocarditis), tissue Doppler (ARVC), 
sodium channel blocker challenge (Brugada syndrome), 
and adenosine challenge for pre-excitation (familial risk 
of WPW syndrome and supraventricular tachycardia). 
These tests are not appropriate for mass screening due 
to low yield and also due to the need for expertise to 
successfully obtain and interpret the results. They 
become important after screening has raised concerns 
for specific problems.  
          Also as shown by Hibachi et al 
[1], there are a 
number of regional considerations in terms of the size 
of the young athlete populations, epidemiology of 
sudden cardiac death, access to technology, and 
economic feasibility. A world wide collaborative effort 
is needed to further delineate various disparate 
considerations pertaining to SCD in young athletes so 
that a more uniform, cohesive and regionally 
appropriate screening and prevent`ion strategy can 
evolve. 
     Identification of young athletes at risk for an adverse 
cardiovascular event during sport participation is a 
challenging task 
[2]. Even in the best of circumstances, 
outcome of sudden cardiac arrest (SCA) on the field 
remains poor; therefore, prevention is critical. 
Cardiovascular screening of young athletes is based on 
ascertaining specific history and a thorough physical 
examination. Although inclusion of an ECG in 
screening asymptomatic athletes has been shown to 
increase the likelihood of identifying athletes at risk, 
considerable logistical and economic challenges 
remain, including using ECG as a screening tool. Even 
the most ideal screening strategy may not identify all 
athletes at risk for SCA on the field, and unfortunately 
SCD may be the first clinical manifestation of some 
cardiac conditions 
[2]. 
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